At the crossroads of epidemiology and biology: bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics

TL;DR

This review links epidemiological data with viral strain properties of SARS-CoV-2, analyzing how infectious dose and viral load relate to epidemic dynamics across different strains and vaccination statuses.

Contribution

It establishes a framework connecting virological and epidemiological insights, illustrating how viral characteristics influence epidemic wave features for multiple SARS-CoV-2 strains.

Findings

Infectious dose varies with viral strain and vaccination status.

Exhaled infectious quanta correlate with epidemic reproduction rate.

Viral load and infectious dose evolution inform epidemic modeling.

Abstract

The COVID-19 pandemic has given rise to numerous articles from different scientific fields (epidemiology, virology, immunology, airflow physics...) without any effort to link these different insights. In this review, we aim to establish relationships between epidemiological data and the characteristics of the virus strain responsible for the epidemic wave concerned. We have carried out this study on the Wuhan, Alpha, Delta and Omicron strains allowing us to illustrate the evolution of the relationships we have highlighted according to these different viral strains. We addressed the following questions: 1) How can the mean infectious dose (one quantum, by definition in epidemiology) be measured and expressed as an amount of viral RNA molecules (in genome units, GU) or as a number of replicative viral particles (in plaque-forming units, PFU)? 2) How many infectious quanta are exhaled by an infected person per unit of time? 3) How many infectious quanta are exhaled, on average, integrated over the whole contagious period? 4) How do these quantities relate to the epidemic reproduction rate R as measured in epidemiology, and to the viral load, as measured by molecular biological methods? 5) How has the infectious dose evolved with the different strains of SARS-CoV-2? We make use of state-of-the-art modelling, reviewed and explained in the appendix of the article (Supplemental Information, SI), to answer these questions using data from the literature in both epidemiology and virology. We have considered the modification of these relationships according to the vaccination status of the population. We hope that this work will allow a better integration of data from different fields (virology, epidemiology, and immunology) to anticipate the evolution of the epidemic in the case of COVID-19, but also in respiratory pathologies transmissible in an airborne manner.